Showing results (251-260 of 269) with videos related to
Sort By:
Pageof 27
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.Science Translational Medicine|April 20, 2022
In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspringSimone Mader, Lior Brimberg, An Vo, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2017
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiersAntonio P Strafella, Nicolaas I Bohnen, Joel S Perlmutter, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 2023
Automatic covariance pattern analysis outperforms visual reading of 18 F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsyRalph Buchert, Florian Wegner, Hans-Jürgen Huppertz, et al.Cerebellum (London, England)|October 14, 2016
Current Opinions and Areas of Consensus on the Role of the Cerebellum in DystoniaVikram G Shakkottai, Amit Batla, Kailash Bhatia, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 6, 2024
Added value of FDG-PET for detection of progressive supranuclear palsyRalph Buchert, Hans-Jürgen Huppertz, Florian Wegner, et al.The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.Parkinsonism & Related Disorders|October 23, 2016
Knowledge gaps and research recommendations for essential tremorFranziska Hopfner, Dietrich Haubenberger, Wendy R Galpern, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.Journal of Parkinson'S Disease|June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopRoger A Barker, Anders Björklund, Don M Gash, et al.Pageof 27